Learn More
Medchemexpress LLC 4-(4-((dimethylamino)methyl)-2,5-dimethoxyphenyl)-2-methyl-2,7-naphthyridin-1(2H)-one | 1883429-22-8 | >98.0% | 353.17 Da | C20H23N3O3 | 100 MG

Supplier: Medchemexpress LLC HY100352100MG
BI-9564 is a potent, selective, and cell-permeable small-molecule inhibitor of the BRD9 bromodomain, with weaker activity against BRD7. Developed through structure-guided design, it binds BRD9 in the low-nanomolar range and has been used as a chemical probe in cellular assays and in vivo studies, including reported oral efficacy in preclinical AML models.
- High affinity for BRD9 with weaker activity against BRD7.
- Demonstrated cellular potency (AlphaScreen IC50 ≈ 75 nM).
- Cell-permeable and suitable for cellular and in vivo studies.
- Validated structural data available (PDB: 5F1H).
- Useful as a research chemical probe to study chromatin remodeling biology.
- Available from multiple research suppliers in small-mass packaging.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.